Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venu Menon

Showing results (231-240 of 347) with videos related to

Pageof 35
Sort By:
American Heart Journal|June 25, 2005
Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?Vladimir Dzavik, Lynn A Sleeper, Michael H Picard, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|May 3, 2005
Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patternsJames W Hoekstra, Matthew T Roe, Eric D Peterson, et al.
The American Journal of Cardiology|January 29, 2013
Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT])Venu Menon, Witold Ruzyllo, Antonio C Carvalho, et al.
Journal of the American College of Cardiology|April 14, 2012
Do bisphosphonates slow the progression of aortic stenosis?Olcay Aksoy, Akin Cam, Sachin S Goel, et al.
Circulation|November 8, 2021
Community-Level Economic Distress, Race, and Risk of Adverse Outcomes After Heart Failure Hospitalization Among Medicare BeneficiariesAmgad Mentias, Milind Y Desai, Mary S Vaughan-Sarrazin, et al.
Angiology|November 20, 2025
Contemporary Trends, Outcomes, and Novel Risk Score for Spontaneous Coronary Artery Dissection: A Nationwide AnalysisAnkit Agrawal, Danny Rayes, Larisa G Tereshchenko, et al.
JACC. Heart Failure|August 15, 2021
A Pragmatic Approach to Weaning Temporary Mechanical Circulatory Support: A State-of-the-Art ReviewVarinder Kaur Randhawa, Abdulrahman Al-Fares, Michael Z Y Tong, et al.
Open Heart|October 7, 2024
Contemporary characteristics, outcomes and novel risk score for Takotsubo cardiomyopathy: a national inpatient sample analysisAnkit Agrawal, Umesh Bhagat, Abdullah Yesilyaprak, et al.
Diabetes Care|December 7, 2019
The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATENishant P Shah, Qiuqing Wang, Katherine E Wolski, et al.
Journal of Hospital Medicine|November 4, 2020
Clinical Characteristics and Outcomes of Non-ICU Hospitalization for COVID-19 in a Nonepicenter, Centrally Monitored Healthcare SystemDavid M Nemer, Bryan R Wilner, Alicia Burkle, et al.
Pageof 35

Showing results (231-240 of 347) with videos related to

Sort By:
Pageof 35
American Heart Journal|June 25, 2005
Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?Vladimir Dzavik, Lynn A Sleeper, Michael H Picard, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|May 3, 2005
Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patternsJames W Hoekstra, Matthew T Roe, Eric D Peterson, et al.
The American Journal of Cardiology|January 29, 2013
Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT])Venu Menon, Witold Ruzyllo, Antonio C Carvalho, et al.
Journal of the American College of Cardiology|April 14, 2012
Do bisphosphonates slow the progression of aortic stenosis?Olcay Aksoy, Akin Cam, Sachin S Goel, et al.
Circulation|November 8, 2021
Community-Level Economic Distress, Race, and Risk of Adverse Outcomes After Heart Failure Hospitalization Among Medicare BeneficiariesAmgad Mentias, Milind Y Desai, Mary S Vaughan-Sarrazin, et al.
Angiology|November 20, 2025
Contemporary Trends, Outcomes, and Novel Risk Score for Spontaneous Coronary Artery Dissection: A Nationwide AnalysisAnkit Agrawal, Danny Rayes, Larisa G Tereshchenko, et al.
JACC. Heart Failure|August 15, 2021
A Pragmatic Approach to Weaning Temporary Mechanical Circulatory Support: A State-of-the-Art ReviewVarinder Kaur Randhawa, Abdulrahman Al-Fares, Michael Z Y Tong, et al.
Open Heart|October 7, 2024
Contemporary characteristics, outcomes and novel risk score for Takotsubo cardiomyopathy: a national inpatient sample analysisAnkit Agrawal, Umesh Bhagat, Abdullah Yesilyaprak, et al.
Diabetes Care|December 7, 2019
The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATENishant P Shah, Qiuqing Wang, Katherine E Wolski, et al.
Journal of Hospital Medicine|November 4, 2020
Clinical Characteristics and Outcomes of Non-ICU Hospitalization for COVID-19 in a Nonepicenter, Centrally Monitored Healthcare SystemDavid M Nemer, Bryan R Wilner, Alicia Burkle, et al.
Pageof 35